Company profile: Kardium
1.1 - Company Overview
Company description
- Provider of the Globe Pulsed Field System for the diagnosis and treatment of atrial fibrillation, integrating pulmonary vein isolation, high-definition mapping, and atrial ablation in a single catheter. Offers the Globe PF Mapping and Ablation System with a 122-electrode catheter, the Globe Catheter (30 mm spherical array, 122 electrodes), and the PULSAR clinical study evaluating safety and effectiveness.
Products and services
- Globe Catheter: A multi-electrode, 30 mm spherical-array catheter with 122 electrodes that creates high-definition anatomical and electrical maps and delivers pulsed electric field energy for atrial fibrillation treatment
- Globe® PF Mapping and Ablation System: A single-catheter platform that offers rapid pulmonary vein isolation, high-resolution mapping, and atrial ablation with a catheter equipped with 122 electrodes
- Globe® Pulsed Field (PF) System: A catheter-based platform that combines pulmonary vein isolation, high-definition mapping, and atrial ablation in a single catheter for atrial fibrillation treatment
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Kardium
Jupiter Endovascular
HQ: United States
Website
- Description: Provider of endovascular medical technologies, including the Vertex Pulmonary Embolectomy System to treat acute pulmonary embolism with enhanced control and precision, and Endoportal Control, a platform that enhances catheter interventions by providing stability and control for access to difficult anatomical sites.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Jupiter Endovascular company profile →
Okami Medical
HQ: United States
Website
- Description: Provider of devices for heart disease treatment, including the LOBO Vascular Occlusion System—a low-profile braided occluder enabling rapid, reliable peripheral artery vessel occlusion. Offerings include LOBO-3 (cleared for peripheral artery occlusion) and LOBO-5, LOBO-7, and LOBO-9 (FDA 510(k) cleared) for peripheral embolization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Okami Medical company profile →
Minvasys
HQ: France
Website
- Description: Provider of solutions for the treatment of cardiovascular disorders.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Minvasys company profile →
BioVentrix
HQ: United States
Website
- Description: Provider of medical devices and clinical programs for congestive heart failure: the Revivent TC TransCatheter Ventricular Enhancement System to reshape the left ventricle and improve function by excluding scarred tissue using micro-anchor implants; the ALIVE clinical study for LV scarring; NYHA III–IV patient identification criteria and training; and an educational resource library.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioVentrix company profile →
EPD Solutions
HQ: Spain
Website
- Description: Provider of cardiac imaging and navigation systems, dedicated to improving the efficacy and efficiency of minimally invasive catheter-based procedures to treat cardiac arrhythmias; a Dutch company and member of the Hobart Group companies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full EPD Solutions company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Kardium
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Kardium
2.2 - Growth funds investing in similar companies to Kardium
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Kardium
4.2 - Public trading comparable groups for Kardium
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →